Fiani Brian, Reardon Taylor, Ayres Benjamin, Cline David, Sitto Sarah R
Neurosurgery, Desert Regional Medical Center, Palm Springs, USA.
Medicine, University of Pikeville-Kentucky College of Osteopathic Medicine, Pikeville, USA.
Cureus. 2021 Mar 30;13(3):e14192. doi: 10.7759/cureus.14192.
The human brain is one of the most mystifying biological structures in nature. Overwhelming research, technology, and innovations in neuroscience have augmented clinical assessments, diagnosis, and treatment capabilities. Nonetheless, there is still much to be discovered about nervous system disorders and defects. Neuralink, a neurotechnology company, is advancing the field of neuroscience and neuroengineering. The company's initial aim is to develop an implantable brain-machine interface device that will enhance the lives of people with severe brain and spinal cord injuries. Here, we provide insight into Neuralink's design, early testing, and future applications in neurosurgery. While early testing with small and large animals show promising results, no clinical trials have been conducted to date. Additionally, a term search for "Neuralink" was performed in PubMed. The literature search yielded only 28 references, of which most indirectly mentioned the device but not in direct testing. In order to conclude the safety and viability of the Neuralink device, further research studies are needed to move forward beyond speculation.
人类大脑是自然界中最神秘的生物结构之一。神经科学领域大量的研究、技术和创新提升了临床评估、诊断和治疗能力。尽管如此，关于神经系统疾病和缺陷仍有许多有待发现之处。Neuralink是一家神经技术公司，正在推动神经科学和神经工程领域的发展。该公司的最初目标是开发一种可植入的脑机接口设备，以改善严重脑损伤和脊髓损伤患者的生活。在此，我们深入了解Neuralink的设计、早期测试以及在神经外科手术中的未来应用。虽然对小型和大型动物的早期测试显示出了有前景的结果，但迄今为止尚未进行临床试验。此外，在PubMed上对“Neuralink”进行了术语搜索。文献搜索仅产生了28篇参考文献，其中大多数只是间接提及该设备，而非直接测试。为了确定Neuralink设备的安全性和可行性，需要进一步的研究来超越推测向前推进。
